EICHOR
● Recruiting
A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG11001 )
Condition: B-Cell Non-Hodgkin Lymphoma · Sponsor: Tongji Hospital
About this study
A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma.
This description comes directly from the study's public registry record.
Talk to the study team
Yicheng Zhang MD,Ph.D., MD · +86 18607140317 · yczhang@tjh.tjmu.edu.cn
Yicheng Zhang MD, Ph.D · +86 18607140317 · yczhang@tjh.tjmu.edu.cn
Always discuss trial participation with your own doctor first.
Locations (1)
| Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology | Wuhang, Hubei, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.